ERNST TIMOTHY S 4

Accession 0001062993-23-017650

CIK 0000012208other

View on SEC.gov Company Profile

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 1:06 PM ET

Size

30.8 KB

Accession

0001062993-23-017650

Insider Transaction Report

Form 4

Period: 2023-09-01

BIO-RAD LABORATORIES, INC.BIO BIOB

ERNST TIMOTHY S

EVP, General Counsel & Sec

Transactions

Exercise/Conversion
Bio-Rad A Common Stock
2023-09-01+347→ 2,762.797 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-01+253→ 2,842.797 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-02+361→ 3,077.797 total
Tax Payment
Bio-Rad A Common Stock
2023-09-02$394.60/sh−179$70,633→ 2,898.797 total
Exercise/Conversion
Restricted Stock Units
2023-09-01−253→ 507 total
Exercise: $0.00→ Bio-Rad A Common Stock (253 underlying)
Exercise/Conversion
Restricted Stock Units
2023-09-03−464→ 464 total
Exercise: $0.00→ Bio-Rad A Common Stock (464 underlying)
Tax Payment
Bio-Rad A Common Stock
2023-09-03$394.60/sh−231$91,153→ 3,131.797 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-04+500→ 3,631.797 total
Exercise/Conversion
Restricted Stock Units
2023-09-02−361→ 361 total
Exercise: $0.00→ Bio-Rad A Common Stock (361 underlying)
Tax Payment
Bio-Rad A Common Stock
2023-09-01$394.60/sh−173$68,266→ 2,589.797 total
Award
Restricted Stock Units
2023-09-01+2,003→ 2,003 total
Exercise: $0.00→ Bio-Rad A Common Stock (2,003 underlying)
Exercise/Conversion
Restricted Stock Units
2023-09-04−500→ 0 total
Exercise: $0.00→ Bio-Rad A Common Stock (500 underlying)
Tax Payment
Bio-Rad A Common Stock
2023-09-01$394.60/sh−126$49,720→ 2,716.797 total
Exercise/Conversion
Bio-Rad A Common Stock
2023-09-03+464→ 3,362.797 total
Tax Payment
Bio-Rad A Common Stock
2023-09-04$394.60/sh−248$97,861→ 3,383.797 total
Exercise/Conversion
Restricted Stock Units
2023-09-01−347→ 1,041 total
Exercise: $0.00→ Bio-Rad A Common Stock (347 underlying)

Footnotes (8)

[F1]Shares of Class A common stock acquired on the vesting of restricted stock units.
[F2]Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
[F3]The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
[F4]On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F5]On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F6]On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
[F7]On September 3, 2019, the reporting person was granted 2,320 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
[F8]On September 4, 2018, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

→

Entity typeother

Related Parties

filerCIK 0001676291

Filing Metadata

Form type: 4
Filed: Sep 5, 8:00 PM ET
Accepted: Sep 6, 1:06 PM ET
Size: 30.8 KB

View on SEC.gov